Chirag Rajkumar Kopp
@chiragkopp
Associate consultant @Apollomedics. Rheumatologist, MD,DM. Alumni- PGIMER. Life's beautiful.
ID: 1231805985871843330
24-02-2020 05:00:26
267 Tweet
415 Followers
249 Following
Scleroderma therapeutics: we’re actually getting some choices! Christian Dejaco #EULAR2023 Dr. John Cush
Overlap syndrome of anti‐aquaporin 4 positive neuromyelitis optica spectrum disorder and primary Sjögren’s syndrome is rare but can be challenging. Sharing our systematic review rdcu.be/dhV21 Chandra Bhushan Prasad Chirag Rajkumar Kopp Vishal Sharma Laurent ARNAUD
pubmed.ncbi.nlm.nih.gov/37487596/ Similarly it is a challenge in SLE also. Sharing the link for our systematic review Chirag Rajkumar Kopp Chandra Bhushan Prasad Vishal Sharma Laurent ARNAUD
Pleased to share our systematic review on SLE-AQP4+NMOSD featured on spotlight of Neurology live. AMAN SHARMA 🇮🇳 Chandra Bhushan Prasad Durga Prasanna Misra Vishal Sharma Vikas Agarwal
🚨 1/ Treatment of Systemic Sclerosis-associated ILD: an official ATS American Thoracic Society (ATS) guideline Main takeaways and some reflections now wearing my methodologist hat 🤠: + atsjournals.org/doi/abs/10.116…
Important plenary re:reduced vs standard GC for AAV... IRL PEXIVAS & recent guidelines supported low dose taper Real world data w/severe dx? Increased risk of death & ESKD for REDUCED pts Need full data but yikes... Dr. John Cush #ACR23 #ACRBest